XENOPORT INC Business Operations Contracts & Agreements
15 Contracts & Agreements
- Development Agreements (14 contracts)
- Supply Agreements (1)
- MASTER MANUFACTURING AND SUPPLY AGREEMENT BETWEEN XenoPort, Inc., AND PatheonPharmaceuticals Inc., DATED AS OF September 25, 2013. TABLE OF CONTENTS (Filed With SEC on November 8, 2013)
- our access to information related to the parent drugs of our product candidates may not reduce the risks and time associated with drug development (Filed With SEC on April 13, 2005)
- our access to information related to the parent drugs of our product candidates may not reduce the risks and time associated with drug development (Filed With SEC on April 13, 2005)
- our access to information related to the parent drugs of our product candidates may not reduce the risks and time associated with drug development (Filed With SEC on April 13, 2005)
- our access to information related to the parent drugs of our product candidates may not reduce the risks and time associated with drug development (Filed With SEC on April 13, 2005)
- our access to information related to the parent drugs of our product candidates may not reduce the risks and time associated with drug development (Filed With SEC on April 13, 2005)
- our access to information related to the parent drugs of our product candidates may not reduce the risks and time associated with drug development (Filed With SEC on April 13, 2005)
- our access to information related to the parent drugs of our product candidates may not reduce the risks and time associated with drug development (Filed With SEC on April 13, 2005)
- our access to information related to the parent drugs of our product candidates may not reduce the risks and time associated with drug development (Filed With SEC on March 2, 2005)
- our access to information related to the parent drugs of our product candidates may not reduce the risks and time associated with drug development (Filed With SEC on March 2, 2005)
- our access to information related to the parent drugs of our product candidates may not reduce the risks and time associated with drug development (Filed With SEC on March 2, 2005)
- our access to information related to the parent drugs of our product candidates may not reduce the risks and time associated with drug development (Filed With SEC on March 2, 2005)
- our access to information related to the parent drugs of our product candidates may not reduce the risks and time associated with drug development (Filed With SEC on March 2, 2005)
- our access to information related to the parent drugs of our product candidates may not reduce the risks and time associated with drug development (Filed With SEC on March 2, 2005)
- our access to information related to the parent drugs of our product candidates may not reduce the risks and time associated with drug development (Filed With SEC on March 2, 2005)
